Effects of epidermal growth factor and its signal transduction inhibitors on apoptosis in human colorectal cancer cells

J. C J Chao, Wen L. Peng, Sheng-Hsuan Chen

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Aim: The study investigated if EGF signaling inhibitors, EGF antibody and tyrphostin 51 (a tyrosine kinase inhibitor), mediated the action of EGF on apoptosis and the expression of EGF receptors and p21 (a cyclin-dependent kinase inhibitor) of human colorectal cancer cells. Methods: Human colorectal adenocarcinoma cells (SW480) were incubated with 0.6 mL/L dimethyl sulfoxide (DMSO, the control group), 225 ng/mL (37.5 nmol/L) EGF in 0.6 mL/L DMSO, 225 ng/mL EGF+2.5 μg/mL (17 nmol/L) EGF antibody in 0.6 mL/L DMSO, or 225 ng/mL EGF+215 ng/mL (0.8 μmol/L) tyrphostin 51 in 0.6 mL/L DMSO. Results: After 48 h incubation, the levels of EGF in medium significantly increased (P

Original languageEnglish
Pages (from-to)540-544
Number of pages5
JournalWorld Journal of Gastroenterology
Volume10
Issue number4
Publication statusPublished - Feb 15 2004

Fingerprint

Epidermal Growth Factor
Colorectal Neoplasms
Signal Transduction
Apoptosis
Dimethyl Sulfoxide
Cyclin-Dependent Kinase Inhibitor p21
Antibodies
Protein-Tyrosine Kinases
Adenocarcinoma
Control Groups

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Effects of epidermal growth factor and its signal transduction inhibitors on apoptosis in human colorectal cancer cells. / Chao, J. C J; Peng, Wen L.; Chen, Sheng-Hsuan.

In: World Journal of Gastroenterology, Vol. 10, No. 4, 15.02.2004, p. 540-544.

Research output: Contribution to journalArticle

@article{d1acf4df91414de18bbb4cc22b7ad78a,
title = "Effects of epidermal growth factor and its signal transduction inhibitors on apoptosis in human colorectal cancer cells",
abstract = "Aim: The study investigated if EGF signaling inhibitors, EGF antibody and tyrphostin 51 (a tyrosine kinase inhibitor), mediated the action of EGF on apoptosis and the expression of EGF receptors and p21 (a cyclin-dependent kinase inhibitor) of human colorectal cancer cells. Methods: Human colorectal adenocarcinoma cells (SW480) were incubated with 0.6 mL/L dimethyl sulfoxide (DMSO, the control group), 225 ng/mL (37.5 nmol/L) EGF in 0.6 mL/L DMSO, 225 ng/mL EGF+2.5 μg/mL (17 nmol/L) EGF antibody in 0.6 mL/L DMSO, or 225 ng/mL EGF+215 ng/mL (0.8 μmol/L) tyrphostin 51 in 0.6 mL/L DMSO. Results: After 48 h incubation, the levels of EGF in medium significantly increased (P",
author = "Chao, {J. C J} and Peng, {Wen L.} and Sheng-Hsuan Chen",
year = "2004",
month = "2",
day = "15",
language = "English",
volume = "10",
pages = "540--544",
journal = "World Journal of Gastroenterology",
issn = "1007-9327",
publisher = "WJG Press",
number = "4",

}

TY - JOUR

T1 - Effects of epidermal growth factor and its signal transduction inhibitors on apoptosis in human colorectal cancer cells

AU - Chao, J. C J

AU - Peng, Wen L.

AU - Chen, Sheng-Hsuan

PY - 2004/2/15

Y1 - 2004/2/15

N2 - Aim: The study investigated if EGF signaling inhibitors, EGF antibody and tyrphostin 51 (a tyrosine kinase inhibitor), mediated the action of EGF on apoptosis and the expression of EGF receptors and p21 (a cyclin-dependent kinase inhibitor) of human colorectal cancer cells. Methods: Human colorectal adenocarcinoma cells (SW480) were incubated with 0.6 mL/L dimethyl sulfoxide (DMSO, the control group), 225 ng/mL (37.5 nmol/L) EGF in 0.6 mL/L DMSO, 225 ng/mL EGF+2.5 μg/mL (17 nmol/L) EGF antibody in 0.6 mL/L DMSO, or 225 ng/mL EGF+215 ng/mL (0.8 μmol/L) tyrphostin 51 in 0.6 mL/L DMSO. Results: After 48 h incubation, the levels of EGF in medium significantly increased (P

AB - Aim: The study investigated if EGF signaling inhibitors, EGF antibody and tyrphostin 51 (a tyrosine kinase inhibitor), mediated the action of EGF on apoptosis and the expression of EGF receptors and p21 (a cyclin-dependent kinase inhibitor) of human colorectal cancer cells. Methods: Human colorectal adenocarcinoma cells (SW480) were incubated with 0.6 mL/L dimethyl sulfoxide (DMSO, the control group), 225 ng/mL (37.5 nmol/L) EGF in 0.6 mL/L DMSO, 225 ng/mL EGF+2.5 μg/mL (17 nmol/L) EGF antibody in 0.6 mL/L DMSO, or 225 ng/mL EGF+215 ng/mL (0.8 μmol/L) tyrphostin 51 in 0.6 mL/L DMSO. Results: After 48 h incubation, the levels of EGF in medium significantly increased (P

UR - http://www.scopus.com/inward/record.url?scp=1542345022&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1542345022&partnerID=8YFLogxK

M3 - Article

C2 - 14966913

AN - SCOPUS:1542345022

VL - 10

SP - 540

EP - 544

JO - World Journal of Gastroenterology

JF - World Journal of Gastroenterology

SN - 1007-9327

IS - 4

ER -